Table 1.
Patient, disease, and treatment characteristics for patients in observational and experimental arm.
| Characteristic | Observational Arm (n=28) | Experimental Arm (n=28) |
|---|---|---|
| Age (years) | ||
| Median (Range) | 49 (29-73) | 50 (27-80) |
| Initial tumor size (cm) | ||
| Median (Range) | 3.6 (2.0-12.0) | 3.8 (2.1-10.7) |
| Molecular Markers | ||
| ER+ | 19 | 18 |
| PR+ | 13 | 13 |
| HER2+ | 7 | 8 |
| TNBC | 6 | 8 |
| Histological Type | ||
| IDC | 26 | 25 |
| IMC/Other | 2 | 3 |
| Chemotherapy | ||
| AC-T | 19 | 21 |
| FEC-D | 9 | 7 |
| Trastuzumab | 7 | 8 |
| Treatment Response | ||
| Responder | 26 | 23 (27) |
| Non-Responder | 2 | 5 (1) |
| Response Rate | 93% | 82% (96%) |